Re: Trial Enrollment Difficulties
|
|
Mannkind
|
Jul 04, 2012 02:38AM
|
Let the speculation begin
|
|
Mannkind
|
Mar 09, 2013 08:45AM
|
Re: BMY just listed hundreds of new diabetes sales positions
|
|
Mannkind
|
Aug 06, 2013 10:11PM
|
Re: Who's going to do the talking this time?
|
|
Mannkind
|
Jun 12, 2012 10:00PM
|
Re: Volume surge and CLSN
|
|
Mannkind
|
Jan 31, 2013 09:25AM
|
Re: Anyone listening to the conference?
|
|
Mannkind
|
Jul 10, 2013 12:10PM
|
Re: Novo Nordisk to Begin Phase 3 Studies....
|
|
Mannkind
|
Dec 31, 2012 08:32PM
|
Re: Final 90 days of study.
|
|
Mannkind
|
Oct 14, 2012 11:46PM
|
Re: MannKind Upgraded by JMP Securities to “Market outperform” (MNKD)
|
|
Mannkind
|
Aug 10, 2012 05:01PM
|
Re: Happy to see they are protecting their intellectual property!
|
|
Mannkind
|
Feb 09, 2013 11:31AM
|
Re: Just posted: Adam F predicts positive trial results
|
|
Mannkind
|
Aug 04, 2013 08:11PM
|
Re: Exubera's ghost
|
|
Mannkind
|
Apr 03, 2013 09:03AM
|
Re: Funding News is not so bad
|
|
Mannkind
|
Mar 18, 2013 09:27PM
|
Re: selling
|
|
Mannkind
|
Jan 02, 2013 07:59PM
|
Re: Top Philanthropist for Diabetes
|
|
Mannkind
|
Jun 10, 2012 10:51AM
|
Share buyback
|
|
Mannkind
|
Jul 16, 2013 06:57PM
|
Re: 2013 MannKind Annual Stockholders Meeting Notes
|
|
Mannkind
|
May 28, 2013 07:40AM
|
Re: Forbes
|
|
Mannkind
|
Jul 01, 2012 10:11AM
|
Re: Al's average share price
|
|
Mannkind
|
Nov 04, 2012 03:50PM
|
Re: Why MNKD may be a lousy investment even if Afrezza is a great drug/device
|
|
Mannkind
|
Oct 26, 2012 05:54PM
|